Wellgistics Health Inc (WGRX)
NASDAQHealth CareMedical - DistributionSnapshot 2026-09-04
$3.59+15.06%
Close 2026-07-28 · 1-day change
NASDAQHealth CareMedical - DistributionSnapshot 2026-09-04
Warn: Primary pillar under pressure — Company resolves Nasdaq delisting notice: Nasdaq compliance not confirmed vs Q3 2026 target.
Wellgistics aims to grow revenue to $1.775 million in Q2 2026. The company is actively addressing Nasdaq delisting risks. Recent acquisition efforts align with growth goals. These steps could stabilize and improve the business.
The company is loss-making with negative free cash flow. Nasdaq delisting notice signals serious regulatory risks. Revenue growth is uncertain and the stock has fallen over 65% from its high. These issues could worsen financial health.
The market prices in a turnaround with about 20-36% implied growth over 3-5 years. Our fair value near $1.16 reflects this optionality but also the high risks. The recent sharp selloff shows skepticism about execution and regulatory outcomes.
Breaks if: acquisition fails to contribute meaningfully to revenue or causes operational disruption
Breaks if: company is delisted from Nasdaq or fails to regain compliance by Q3 2026
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a speculative growth opportunity. The company is currently in a state of recovery but faces volatility in management and financial performance.
The market appears to be pricing in an elevated valuation, reflecting a turbulent sector environment. There is a notable premium compared to peers, indicating that expectations may be high given the company's current challenges.
Fundamentals are likely to remain neutral in the near term, as the company has shown slight revenue growth but continues to face losses. Management's focus on vertical integration and blockchain may take time to yield significant results.
The long-term thesis hinges on management's ability to execute its strategic priorities and the overall health of the healthcare sector. Key risks include potential guidance cuts and economic indicators that could impact performance.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: revenue falls below $1.5 million in Q2 2026
In the next 1 to 3 years, WGRX's outlook will depend on its execution and external market conditions. Not investment advice.